Table 1.

Baseline patient demographics and clinical characteristics

Total (N = 65)
Age, years
 Mean (SD)59.7 (11.13)
 Median (range)62.0 (30–79)
 Female, n (%)26 (40)
Race, n (%)
 African American/African2 (3)
 Asian (Central/Southern)1 (2)
 Asian (Eastern)13 (20)
 Caucasian48 (74)
 Unknown1 (2)
Primary tumor type, n (%)
 Colon/rectum23 (35)
 Prostate12 (18)
 Gastric/GE junction7 (11)
 Breast (triple negative)6 (9)
 Ovary/fallopian tube5 (8)
 Endometrium/uterus3 (5)
 NSCLC3 (5)
 CNS2 (3)
 Head and neck2 (3)
 Melanoma1 (2)
 Cervix1 (2)
ECOG status, n (%)
 037 (57)
 128 (43)
Prior lines of therapy, n (%)
 17 (11)
 29 (14)
 34 (6)
 48 (12)
 >437 (57)
  • CNS, central nervous system; ECOG, Eastern Cooperative Oncology Group; GE, gastroesophageal junction; NSCLC, non–small cell lung cancer.